EVH
Evolent Health Inc
3.50$
-2.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 135.1% | 116.9% | 72.5% | 59.2% | 61.0% | 61.9% | 52.3% | 74.7% | 75.3% | 72.4% | 76.6% | 76.6% | 85.6% | 84.9% | |
| -35.1% | -16.9% | 27.5% | 40.8% | 39.0% | 38.1% | 47.7% | 25.3% | 24.7% | 27.6% | 23.4% | 23.4% | 14.4% | 15.1% | |
| – | 7.8% | 4.0% | 6.0% | 4.4% | 4.0% | 2.9% | 2.9% | 2.6% | 2.9% | 2.0% | 1.4% | – | – | |
| – | 60.8% | 75.8% | 77.7% | 63.2% | 47.3% | 48.8% | 57.2% | 33.6% | 24.2% | 18.2% | 18.2% | 10.3% | 16.2% | |
| 200.0% | 65.5% | -25.0% | 85.1% | 70.0% | 54.7% | 55.9% | 70.3% | 53.1% | 32.3% | 23.1% | 27.1% | 16.0% | 15.4% | |
| -235.1% | -82.4% | -25.0% | -44.4% | -93.4% | -16.7% | -7.6% | -45.0% | -28.4% | -4.7% | 0.3% | -3.6% | -1.6% | -0.2% | |
| – | 3.2% | 0.0% | 0.3% | 0.3% | 0.8% | 0.9% | 2.1% | 3.1% | 2.8% | 1.2% | 2.8% | 1.0% | 3.1% | |
| -234.8% | 78.0% | -25.0% | 354.4% | -93.4% | -17.6% | -8.6% | -48.0% | -35.7% | -3.3% | -4.6% | -10.3% | -2.5% | -28.5% | |
| -4.0% | 0.0% | 0.0% | 24.2% | -4.2% | -1.5% | 0.0% | -3.3% | -0.3% | 0.1% | -3.2% | -4.6% | -0.1% | 0.0% | |
| -230.8% | 78.0% | -25.0% | 343.2% | -62.8% | -13.9% | -8.4% | -43.9% | -36.1% | -4.1% | -1.4% | -5.8% | -2.4% | -28.5% | |
| -233.7% | -79.3% | -25.0% | -32.5% | -86.7% | -9.3% | -0.7% | -37.0% | -26.0% | 6.1% | 3.2% | -1.3% | 3.3% | -19.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.